{"entity":{"id":"nct07605962","kind":"trial","name":"Phase 1/2 Study of UI-102 in Selected Advanced Cancers","aka":[],"tldr":"A phase 1/2 trial of UI-102 in advanced solid tumours, run by United Immunity, co., Ltd., now recruiting.","summary":"Phase 1/2 Study of UI-102 in Selected Advanced Cancers is a phase 1/2 interventional study registered as NCT07605962 by United Immunity, co., Ltd., with 140 participants planned, started 2026-05-20 and due to reach its primary completion in 2030-03-31. Interventions recorded: UI-102.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07605962","url":"https://clinicaltrials.gov/study/NCT07605962"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":["tlr7"],"drugs":[],"companies":["united-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07605962","phase":"1/2","setting":"A Phase I/II Open-Label, Dose Escalation, Dose Optimization, and Cohort Expansion Trial to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of UI-102, a Novel Cholesteryl Pullulan (CHP) Nanoparticle-formulated TLR7/8 Agonist in Patients With Selected Locally Advanced and/or Metastatic Solid Tumors","sponsor":"United Immunity, co., Ltd.","participation":[{"nct":"NCT07605962","source":"https://clinicaltrials.gov/study/NCT07605962","fetchedAt":"2026-10-07T16:55:51.217Z","studySha256":"37f4cccf2a04a6ee0fd427772b6cffc929ded14cc1bd098b91efbaee8c6a1255","overallStatus":"RECRUITING","lastUpdatePosted":"2026-06-03","leadSponsor":"United Immunity, co., Ltd.","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":140,"enrolmentType":"ESTIMATED","siteCount":3,"recruitingSiteCount":3,"countries":["United States"]}],"started":"2026-05-20","startedType":"actual","enrolled":140,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07605962/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"target":[{"id":"tlr7","kind":"target","name":"Toll-like receptor 7 (TLR7)","route":"/targets/tlr7/"}],"company":[{"id":"united-therapeutics","kind":"company","name":"United Therapeutics","route":"/companies/united-therapeutics/"}]}}